Figure 3.
Total direct cost breakdown for each diagnostic strategy: in green, the costs of clinical procedures and resource utilisation needed to reach diagnosis, in blue the costs brought about by colonoscopy-related complications, and in red the costs ascribable to those patients with relevant colonic pathology that were missed in each diagnostic strategy. (a) Colonoscopy; (b) FOBT; (c) FC; (d) FOBT+FC.
FC, faecal calprotectin; FOBT, faecal occult blood test.
